Request Scientific White Paper

Predicting the Placebo Response to Reduce Clinical Data Variability and De-Risk Drug Development

Placebo-controlled, randomized clinical trials are the gold standard to evaluate drug safety and efficacy in drug development; yet, distinguishing true drug efficacy from the placebo response presents a significant challenge. This white paper examines the issue of the placebo response from multiple angles, and presents the background and scientific data resulting from the development of Placebell©™, Tools4Patient’s innovative approach to reduce the impact of the placebo response in clinical trials.

Topics include:

  • The challenge of the placebo response in clinical trials
  • Existing methods to manage the placebo response in drug development
  • The development of the Placebell©™ method
  • Clinical data using Placebell©™ in neuropathic pain
  • Expansion of Placebell©™ to indications outside of pain

Complete the form below to request your copy of this scientific white paper.

Predicting the Placebo Response to Reduce Clinical Data Variability and De-Risk Drug Development
  • This field is for validation purposes and should be left unchanged.